F-star Therapeutics, Inc. (Nasdaq – FSTX)

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of F-star Therapeutics, Inc. (Nasdaq – FSTX) BALA CYNWYD – June 23, 2022 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of F-star Therapeutics, Inc. Inc. (“F-star” or the “Company”) (Nasdaq – FSTX) for … Continue reading F-star Therapeutics, Inc. (Nasdaq – FSTX)